| Description |
Over the past decade, our research group has worked on developing surface-based immunoassays to detect disease biomarkers. Our immunoassay platforms use a gold surface coated with an N-hydroxysuccinimide (NHS)-based monolayer and a layer of antibodies to capture a target antigen. Readout is achieved by surface-enhanced Raman scattering (SERS) or giant magnetoresistance (GMR) after labeling of the captured antigen with Raman dye-modified gold nanoparticles or magnetic particles, which are also coated with antibodies. Both of these platforms enable the low-level detection of numerous biomarkers and have the potential for translation into a point-of-need (PON) (i.e., rapid, easy to use, and field deployable) test. As part of an effort to develop a PON test, this dissertation includes investigations of: (1) SERS-based detection of botulinum neurotoxins (BoNTs), (2) protein immobilization procedures, and (3) magnetic microcapsules (MMCs) for use with GMR detection. First, a SERS-based immunoassay for bioterrorism agents, botulinum neurotoxins A (BoNT-A) and B (BoNT-B) with picomolar (or lower) detection limits for BoNT-A and; BoNT-B in buffer and serum is described. These results not only demonstrate sufficient detection of these markers at levels important to homeland security and human health monitoring, but also the potential to translate this methodology to a PON test. Next, the reactivity of NHS ester-terminated monolayers, a common approach in protein immobilization chemistry, is investigated to assess the competition of the purported amidization reaction to that of hydrolysis. Results of kinetic studies on hydrolysis and aminolysis under relevant assay conditions show the rate of hydrolysis is 300× faster than that of aminolysis. These results indicate that it is highly unlikely that proteins are covalently linked to the surface and suggest that the protein layer is adsorbed via hydrophobic, hydrogen bonding, and electrostatic interactions. The last section examines the development of an MMC-based label. With marked improvement in both stability and magnetization over commercially-available magnetic nanoparticles, these MMCs show potential for the eventual enhanced function as a label in a GMR-based immunoassay. With these results, this dissertation aims to set the stage for the rational development of assays that will facilitate a paradigm shift towards PON tests. |
